{"id":10097,"date":"2007-08-13T00:00:24","date_gmt":"2007-08-12T22:00:24","guid":{"rendered":"http:\/\/www.fedaiisf.it\/gsk-chiesta-introduzione-vaccino-hpv\/"},"modified":"2007-08-13T00:00:24","modified_gmt":"2007-08-12T22:00:24","slug":"gsk-chiesta-introduzione-vaccino-hpv","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/gsk-chiesta-introduzione-vaccino-hpv\/","title":{"rendered":"Gsk, HPV vaccine introduction requested"},"content":{"rendered":"<div>\n<p><span class=\"Style_3\">&nbsp;Following the positive opinion of the European Committee for Medicinal Products for Human Use, <span class=\"Style_6\">GlaxoSmithKIine Italy<\/span> has applied to the<span class=\"Style_6\">Alpha <\/span>(Italian Medicines Agency) for the introduction in the NHS of its vaccine for the prevention of <span class=\"Style_6\">cervical cancer<\/span>. Cervical cancer is the second leading cause of death in women under 45 and is responsible for <span class=\"Style_6\">270,000 dead a year<\/span>. From Il Sole 24 Ore Sanita&#039; of 10\/08\/2007 N. 31\/32 7-20 AUGUST 2007<\/span>&nbsp;&nbsp;&nbsp;<\/p>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>&nbsp;Dopo il parere positivo del Comitato europeo per i medicinali a uso umano, GlaxoSmithKIine Italia ha presentato domanda all&#8217;Alfa (Agenzia italiana del farmaco) per l&#8217;introduzione nel Ssn del suo vaccino per la prevenzione del cervicocarcinoma. Il tumore della cervice uterina &#232; la seconda causa di morte nelle donne con meno di 45 anni ed &#232; &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-10097","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=10097"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=10097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=10097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=10097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}